Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

768
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
768
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.2K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques01:30

Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

903
Airway management is essential in emergency and surgical medicine, ensuring ventilation and oxygenation in patients who cannot maintain their own airway. Clinicians use a range of techniques and devices to secure the airway, depending on the patient’s condition and the clinical context. Key methods include endotracheal intubation, rapid sequence intubation (RSI), supraglottic airway devices, and advanced visualization aids. In cases where these approaches fail, surgical airway...
903
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic Assessment of Exercise Gas Exchange Efficiency by Breath-by-Breath Volumetric Capnography in Mild-Moderate COPD.

COPD·2026
Same author

Inhaler Technique in Chronic Obstructive Pulmonary Disease: Patient Impairments and Bronchodilation.

Annals of the American Thoracic Society·2026
Same author

Poor Sleep Quality and Heightened Perceptual Responses to Exercise in Community Dwellers: Results from the CanCOLD Study.

Annals of the American Thoracic Society·2026
Same author

Postural relief of dyspnoea is associated with improved neuromechanical coupling in patients with advanced COPD.

The European respiratory journal·2026
Same author

The role of the pulmonary function laboratory in risk assessment for lung resection.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2026
Same author

The role of the pulmonary function laboratory in the assessment of adults with neuromuscular disease.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2026

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance
06:26

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance

Published on: September 27, 2024

1.1K

Recent advances in dyspnea.

Donald A Mahler1, Denis E O'Donnell2

  • 1Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH.

Chest
|January 7, 2015
PubMed
Summary
This summary is machine-generated.

Dyspnea, or shortness of breath, is a common symptom in heart and lung diseases. Opioids and bronchodilators can help manage dyspnea in patients with chronic obstructive pulmonary disease (COPD).

More Related Videos

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.7K
Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

13.9K

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance
06:26

Author Spotlight: Exploring Breathing Techniques and Digital Solutions for Enhancing Running Performance

Published on: September 27, 2024

1.1K
Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

14.7K
Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

13.9K

Area of Science:

  • Pulmonary Medicine
  • Cardiology
  • Neuroscience

Background:

  • Dyspnea is a prevalent symptom in cardiac and respiratory diseases, predicting mortality.
  • Endogenous opioids modulate dyspnea in chronic obstructive pulmonary disease (COPD).
  • Neuroimaging reveals a cortical-limbic network involved in dyspnea perception.

Purpose of the Study:

  • To review the current understanding and management of dyspnea.
  • To highlight the role of opioids and bronchodilators in COPD dyspnea.
  • To discuss novel and experimental treatments for refractory dyspnea.

Main Methods:

  • Review of existing literature on dyspnea.
  • Analysis of studies on opioid receptor signaling and neuroimaging.
  • Examination of treatment guidelines and emerging therapies for COPD.

Main Results:

  • Dyspnea perception involves sensory, affective, and impact components.
  • Resting inspiratory capacity influences exercise dyspnea in COPD.
  • Long-acting bronchodilators and opioids offer relief for COPD-related dyspnea.

Conclusions:

  • Dyspnea management in COPD benefits from bronchodilators and opioids.
  • Low-dose opioids are recommended for refractory dyspnea.
  • Experimental therapies like acupuncture and volume reduction show promise but need more evidence.